OGG1 and cancer: Recently, the first example of a cell-active inhibitor targeting OGG1 has been reported23 as well as details on how TH5487 binds to the human OGG1 sensitizing cancer cell lines by inducing replication stress without increasing nuclear 8-oxoG levels24,25.